VIVUS, Inc. (NASDAQ: VVUS)

VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company, is focused on developing and commercializing next-generation therapeutic products designed to target obesity and sexual health. The potential market for obesity ranges from $5 billion to $10 billion annually according to speculating analysts, while the potential market for an effective diabetes therapy that causes weight loss is in excess of $2 billion. The indications targeted by VIVUS’ sexual health products each represent a potential market of more than $1 billion per annum. For further information, visit the Company’s web site at www.vivus.com.